← Leaderboards
Jeffrey M Bhasin
Cleveland Clinic Lerner Com-Cwru
$64,862
Attributed
$64,862
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.1K · FY2015–16$50K$37.5K$25K$12.5K$0
'15
'16
Funding mix
By agency
NIH$64,862 · 2
By mechanism
F31$55,741 · 1
F99$9,121 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Kailash Gulshan$2,659,514
- Hannelore Heemers$4,990,015
- Angela H Ting$5,070,113
- Vinod D Labhasetwar$14,028,234
- Bethany Amber Kerr$1,020,310
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateProstate Cancer Cell LineFutureLeadModificationPathway InteractionsEnhancersEpigenetic ProcessGene TargetingIndolentDiagnosticMalignant NeoplasmsAmericanMolecularDistalDna MethylationBinding SitesCell LineGene ExpressionGenesChromatinGenome EditingBehaviorTissues
Grant awards (3)
The function of differential DNA methylation in aggressive prostate cancer$22,602
F31 · FY2016 · CA · contact PI
Interrogating the role of non-promoter epigenetic aberrations in cancer$9,121
F99 · FY2016 · CA · contact PI
The function of differential DNA methylation in aggressive prostate cancer$33,139
F31 · FY2015 · CA · contact PI